UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Dacarbazine - adverse effects | Follow-Up Studies | Dacarbazine - therapeutic use | Mitosis | Humans | Middle Aged | Male | Electric Stimulation Therapy | Chemoradiotherapy | Glioblastoma - radiotherapy | Glioblastoma - surgery | Antineoplastic Agents, Alkylating - therapeutic use | Disease-Free Survival | Dacarbazine - analogs & derivatives | Survival Analysis | Adult | Female | Aged | Maintenance Chemotherapy | Temozolomide | Antineoplastic Agents, Alkylating - adverse effects | Glioblastoma - drug therapy | Chemotherapy | Usage | Patient outcomes | Dosage and administration | Drug therapy | Glioblastoma multiforme | Cancer | Statistical analysis | Toxicity | Glioblastoma | Central nervous system | Clinical trials | Cell division | Nervous system | Maintenance | Patients | Survival | Scalp | Skin | Portable equipment | Electric fields | Tumors | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
Head & neck, ISSN 1043-3074, 04/2009, Volume 31, Issue 4, pp. 429 - 441
head and neck | guidelines | laryngeal | carcinoma | larynx preservation | hypopharyngeal | Head and neck | Laryngeal | Larynx preservation | Carcinoma | Hypopharyngeal | Guidelines | Otorhinolaryngology | Life Sciences & Biomedicine | Surgery | Science & Technology | Otorhinolaryngology. Stomatology | Biological and medical sciences | Medical sciences | Hypopharyngeal Neoplasms - surgery | Guidelines as Topic | Laryngeal Neoplasms - surgery | Carcinoma, Squamous Cell - pathology | Humans | Hypopharyngeal Neoplasms - physiopathology | Carcinoma, Squamous Cell - surgery | Survival Rate | Combined Modality Therapy | Hypopharyngeal Neoplasms - mortality | Carcinoma, Squamous Cell - physiopathology | Laryngectomy | Laryngeal Neoplasms - pathology | Deglutition | Disease-Free Survival | Clinical Trials, Phase III as Topic - standards | Carcinoma, Squamous Cell - mortality | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Larynx - physiopathology | Speech | Laryngeal Neoplasms - physiopathology | Index Medicus
Journal Article
Critical care medicine, ISSN 0090-3493, 07/2014, Volume 42, Issue 7, pp. 1714 - 1721
clinical trial design | tumor necrosis factor antibody | septic shock | severe sepsis | sepsis | intensive care units | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Infectious diseases | Bacterial diseases | Human bacterial diseases | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Biological and medical sciences | Intensive care medicine | Emergency and intensive care: infection, septic shock | Medical sciences | Bacterial sepsis | Recombinant Proteins - therapeutic use | Drug Evaluation, Preclinical - methods | Sepsis - drug therapy | Fibrinolytic Agents - therapeutic use | Humans | Biomarkers | Clinical Trials, Phase II as Topic - methods | Research Design | Protein C - therapeutic use | Clinical Trials, Phase III as Topic - methods | Index Medicus | Abridged Index Medicus
Journal Article
Influenza and other respiratory viruses, ISSN 1750-2640, 05/2017, Volume 11, Issue 3, pp. 240 - 246
clinical trial | effectiveness | influenza | influenza virus | development | antiviral | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Virology | Clinical Trials, Phase III as Topic | Humans | Influenza, Human - virology | Orthomyxoviridae - drug effects | Influenza, Human - drug therapy | Antiviral Agents - administration & dosage | Orthomyxoviridae - physiology | Clinical Trials, Phase II as Topic | Drugs | Medical research | Antiviral agents | Animal models | Pandemics | Clinical trials | Viruses | Infections | Patients | Polymerase | Oseltamivir | Molecular modelling | Influenza | Monoclonal antibodies | In vitro methods and tests | Index Medicus | Expert
Journal Article
Annals of internal medicine, ISSN 0003-4819, 08/2016, Volume 165, Issue 4, pp. 270 - 278
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Genomics | Humans | Clinical Trials, Phase I as Topic - methods | Clinical Trials as Topic - methods | Clinical Trials, Phase II as Topic - methods | Research Design | Clinical Trials, Phase IV as Topic - methods | Precision Medicine - methods | Clinical Trials, Phase III as Topic - methods | Neoplasms - drug therapy | Evaluation | Care and treatment | Innovations | Clinical trials | Genotype | Testing | Cancer | Oncology | Cancer therapies | Research methodology | Index Medicus | Abridged Index Medicus
Journal Article
Cancer science, ISSN 1347-9032, 07/2015, Volume 106, Issue 7, pp. 883 - 890
phase II/III | elpamotide | Advanced pancreatic cancer | peptide vaccine | immunotherapy | Peptide vaccine | Elpamotide | Immunotherapy | Phase II/III | Life Sciences & Biomedicine | Oncology | Science & Technology | Adenocarcinoma - pathology | Carcinoma, Adenosquamous - pathology | Double-Blind Method | Cancer Vaccines - administration & dosage | Deoxycytidine - administration & dosage | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Peptide Fragments - administration & dosage | Kaplan-Meier Estimate | Carcinoma, Adenosquamous - drug therapy | Male | Treatment Outcome | Adenocarcinoma - drug therapy | Pancreatic Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Adenosquamous - mortality | Adult | Female | Aged | Pancreatic Neoplasms - mortality | Vascular Endothelial Growth Factor Receptor-2 - administration & dosage | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Statistical analysis | Gemcitabine | Peptides | Toxicity | Clinical trials | Metastasis | Radiation therapy | Cancer therapies | Survival | Patients | Blood | Metastases | Angiogenesis | Chemotherapy | Pancreatic cancer | Medical prognosis | Vascular endothelial growth factor receptor 2 | Vascular endothelial growth factor | Index Medicus | phase II | III | Original
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 01/2014, Volume 32, Issue 2, pp. 83 - 89
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Clinical Trials, Phase III as Topic - standards | Adverse Drug Reaction Reporting Systems - standards | Humans | Linear Models | Publications - standards | Research Report - standards | Neoplasms - drug therapy | Randomized Controlled Trials as Topic - standards | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 2014, Volume 32, Issue 14, pp. 1407 - 1411
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Pneumology | Lung Neoplasms - drug therapy | Clinical Trials, Phase III as Topic - standards | Lung Neoplasms - mortality | Humans | Clinical Trials, Phase III as Topic - trends | Research Design - standards | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - drug therapy | Research Design - trends | Carcinoma, Non-Small-Cell Lung - mortality | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 08/2016, Volume 128, Issue 5, pp. 630 - 637
Clinical Trial, Phase III | Immunology | Hematology | Medicine(all) | Multicenter Study | Biochemistry | Clinical Trial, Phase I | Journal Article | Cell Biology | Life Sciences & Biomedicine | Science & Technology | Hemostasis - drug effects | Recombinant Proteins - therapeutic use | Demography | Factor VIII - pharmacokinetics | Humans | Middle Aged | Male | Recombinant Proteins - pharmacokinetics | Treatment Outcome | Recombinant Proteins - adverse effects | Recombinant Proteins - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Administration, Intravenous | Hemorrhage - drug therapy | Adolescent | Factor VIII - administration & dosage | Adult | Factor VIII - adverse effects | Hemophilia A - prevention & control | Hemophilia A - drug therapy | Child | Factor VIII - therapeutic use | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article